Filing Details

Accession Number:
0001209191-23-002425
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-06 17:32:49
Reporting Period:
2023-01-04
Accepted Time:
2023-01-06 17:32:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1652130 Intellia Therapeutics Inc. NTLA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1563584 M John Leonard C/O Intellia Therapeutics, Inc.
40 Erie Street; Suite 130
Cambridge MA 02139
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-04 6,673 $37.21 766,825 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 58,415 Indirect By Trust
Footnotes
  1. Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 1, 2023.
  2. Shares held by the John M. Leonard 2015 Irrevocable Trust.